MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™ Post published:March 4, 2021 Post category:Press Release
PsyBio Therapeutics Announces Retention of Market Maker Post published:March 4, 2021 Post category:Press Release
PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board Post published:March 4, 2021 Post category:Press Release
Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research Post published:March 4, 2021 Post category:Press Release
MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury Post published:March 4, 2021 Post category:Press Release
atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round Post published:March 3, 2021 Post category:Press Release
Cybin Inc. Announces Uplisting to OTCQB Venture Market Post published:March 3, 2021 Post category:Press Release
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing Post published:March 3, 2021 Post category:Press Release
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board Post published:March 3, 2021 Post category:Press Release
Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs Post published:March 3, 2021 Post category:Press Release